Finast: Advanced Hair Restoration for Lasting Results
| Product dosage: 1mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $2.02 | $121.12 (0%) | 🛒 Add to cart |
| 90 | $1.97 | $181.68 $177.18 (2%) | 🛒 Add to cart |
| 120 | $1.88 | $242.24 $225.23 (7%) | 🛒 Add to cart |
| 180 | $1.71 | $363.37 $308.31 (15%) | 🛒 Add to cart |
| 270 | $1.59
Best per pill | $545.05 $430.44 (21%) | 🛒 Add to cart |
| Product dosage: 5mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.60 | $78.08 (0%) | 🛒 Add to cart |
| 60 | $2.27 | $156.16 $136.14 (13%) | 🛒 Add to cart |
| 90 | $2.16 | $234.24 $194.20 (17%) | 🛒 Add to cart |
| 120 | $2.09 | $312.32 $251.25 (20%) | 🛒 Add to cart |
| 180 | $2.04 | $468.47 $367.37 (22%) | 🛒 Add to cart |
| 270 | $2.00
Best per pill | $702.71 $540.55 (23%) | 🛒 Add to cart |
Finast represents a significant advancement in the pharmacological management of androgenetic alopecia, offering a scientifically formulated solution to combat hair loss at its hormonal source. This prescription medication contains finasteride as its active ingredient, which specifically targets the enzyme responsible for converting testosterone to dihydrotestosterone (DHT), the primary hormonal driver of pattern hair loss in genetically predisposed individuals. By effectively reducing scalp and serum DHT levels, Finast helps to halt the progressive miniaturization of hair follicles, enabling the restoration of normal hair growth cycles and improved hair density over time. Clinical studies and extensive dermatological use support its efficacy and safety profile when used as directed under medical supervision.
Features
- Contains 1mg of finasteride per tablet, the FDA-approved dosage for male pattern hair loss
- Selective Type II 5-alpha-reductase inhibitor action
- Once-daily oral administration for consistent therapeutic effect
- Manufactured in cGMP-certified facilities ensuring pharmaceutical-grade purity
- Available in blister packs for stability and convenience
- Coated tablets for easier swallowing
Benefits
- Promotes visible hair regrowth in the vertex and anterior mid-scalp areas
- Prevents further progression of hair loss by addressing the underlying hormonal cause
- Demonstrates measurable improvements in hair count within 6-12 months of consistent use
- Supports enhanced hair thickness and overall coverage appearance
- Boosts patient confidence and quality of life through restored appearance
- Provides a clinically validated, non-surgical approach to hair restoration
Common use
Finast is primarily indicated for the treatment of male pattern hair loss (androgenetic alopecia) in men aged 18 years and older. It is prescribed for individuals experiencing gradual thinning at the crown and mid-scalp regions, characterized by the typical Hamilton-Norwood pattern progression. The medication is most effective when initiated during early stages of hair loss, though it may still provide benefit in more advanced cases. Patients typically notice initial effects within 3-6 months of continuous therapy, with optimal results observed after approximately one year of consistent use. Regular follow-up with a healthcare provider is recommended to monitor progress and adjust treatment as needed.
Dosage and direction
The recommended dosage of Finast is one 1mg tablet taken orally once daily, with or without food. For optimal absorption and consistency, patients should establish a regular dosing time each day. Tablets should be swallowed whole with a full glass of water; they should not be crushed or chewed. Treatment response is dependent on continuous therapy, and discontinuation will lead to reversal of beneficial effects within 12 months. Dosage adjustment is not typically required for elderly patients or those with mild to moderate renal impairment, though hepatic impairment requires careful consideration and possible dosage modification under medical guidance.
Precautions
Patients should undergo appropriate medical evaluation before initiating Finast therapy, including assessment of prostate health and baseline PSA levels when indicated. Regular monitoring of sexual function is advised, as some individuals may experience treatment-emergent sexual side effects. Women who are or may become pregnant must not handle crushed or broken tablets due to risk of absorption through the skin and potential fetal harm. Patients should be counseled that initial hair shedding may occur during the first few months of treatment as part of the normal hair cycle synchronization process. Those with liver impairment require careful supervision and possible dosage adjustments.
Contraindications
Finast is contraindicated in women who are pregnant or attempting to conceive due to risk of abnormalities in male fetal genital development. It is also contraindicated in pediatric patients and individuals with known hypersensitivity to finasteride or any component of the formulation. Patients with severe hepatic impairment should not use Finast without thorough risk-benefit assessment and close medical supervision. Those with history of orthostatic hypotension or taking medications that may potentiate this effect should exercise caution and discuss alternative options with their healthcare provider.
Possible side effects
The most commonly reported adverse effects include decreased libido (1.8%), erectile dysfunction (1.3%), and ejaculation disorders (1.2%). These effects typically resolve upon discontinuation of therapy and persist in less than 1% of patients after stopping treatment. Less frequent side effects may include breast tenderness or enlargement, skin rash, and testicular pain. Post-marketing surveillance has reported mood changes including depression in rare cases, though causal relationship remains uncertain. Laboratory abnormalities may include reduced prostate-specific antigen (PSA) levels, which should be considered during prostate cancer screening.
Drug interaction
Finast may interact with medications that inhibit CYP3A4 enzyme activity, such as ketoconazole, itraconazole, and ritonavir, potentially increasing finasteride exposure. Concurrent use with other 5-alpha-reductase inhibitors is not recommended due to potential additive effects. Although no clinically significant interactions have been observed with warfarin, digoxin, propranolol, or theophylline, caution is advised when combining with medications that undergo extensive hepatic metabolism. Patients taking alpha-blockers for hypertension or benign prostatic hyperplasia should be monitored for potential additive hypotensive effects.
Missed dose
If a dose is missed, patients should take it as soon as remembered unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed tablet is not recommended. Consistent daily dosing is important for maintaining stable DHT suppression, though occasional missed doses are unlikely to significantly impact long-term efficacy. Patients should establish routine habits to support adherence, such as using pill organizers or setting daily reminders.
Overdose
No specific antidote for finasteride overdose exists. Single doses up to 400mg and multiple doses up to 80mg daily for three months have been administered without significant adverse effects. In case of suspected overdose, symptomatic and supportive treatment should be initiated. Gastric lavage may be considered if ingestion occurred within a short timeframe. Monitoring should include assessment of cardiovascular status and potential orthostatic hypotension. Given finasteride’s high protein binding, dialysis is unlikely to be beneficial. Medical toxicology consultation is recommended for significant overdoses.
Storage
Store Finast tablets at controlled room temperature between 20°-25°C (68°-77°F), with excursions permitted between 15°-30°C (59°-86°F). Keep in the original blister packaging to protect from moisture and light. Do not transfer tablets to alternative containers that may compromise stability. Keep out of reach of children and pets to prevent accidental ingestion. Properly discard any expired medication according to local pharmaceutical disposal guidelines. Do not flush medications down the toilet or drain unless specifically instructed to do so.
Disclaimer
This information is provided for educational purposes only and does not constitute medical advice. Finast is a prescription medication that should be used only under the supervision of a qualified healthcare professional. Individual results may vary, and not all patients will experience the same degree of benefit. Patients should discuss their specific medical condition, treatment options, and potential risks with their prescribing physician before initiating therapy. The manufacturer and distributors are not liable for any adverse outcomes resulting from improper use or misinterpretation of this information.
Reviews
Clinical studies involving over 3,000 men demonstrated that 83% of Finast users maintained or improved hair count after two years of treatment, with 66% showing significant improvement based on investigator assessment. Post-marketing surveillance data indicates high patient satisfaction rates, particularly among those who begin treatment during early stages of hair loss. Dermatologists consistently report positive outcomes in appropriate candidates, noting the importance of patient education regarding expected timeline for results and potential side effects. Real-world evidence supports the long-term maintenance of benefits with continuous therapy, though individual response varies based on genetic factors, age, and duration of hair loss prior to treatment initiation.